Skin wound healing modulation by macrophages

International Journal of Clinical and Experimental Pathology

Volumn 3, Issue 7, 2010, Pages 643-653

  Rodero, Mathieu P ^a   Khosrotehrani, Kiarash ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Alternatively activated; Cytokines; Growth factors; Healing; Inflammation; M1; Macrophage; Skin wound

Indexed keywords

ANIMAL; CYTOLOGY; HUMAN; IMMUNOLOGY; INFLAMMATION; INJURY; MACROPHAGE; METABOLISM; PHYSIOLOGY; REVIEW; SKIN; WOUND HEALING;

ANIMALS; HUMANS; INFLAMMATION; MACROPHAGES; SKIN; WOUND HEALING;

EID: 77956020077     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Review

References (92)

1. Gordon S and Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005; 5: 953-964.
2. Stout RD and Suttles J. Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J Leukoc Biol 2004; 76: 509-513.
3. Gurtner GC, Werner S, Barrandon Y and Longaker MT. Wound repair and regeneration. Nature 2008; 453: 314-321.
4. Ross R and Odland G. Human wound repair. II. Inflammatory cells, epithelial-mesenchymal interrelations, and fibrogenesis. J Cell Biol 1968; 39: 152-168.
5. Kim MH, Liu W, Borjesson DL, Curry FR, Miller LS, Cheung AL, Liu FT, Isseroff RR and Simon SI. Dynamics of neutrophil infiltration during cutaneous wound healing and infection using fluorescence imaging. J Invest Dermatol 2008; 128: 1812-1820.
6. Leibovich SJ and Ross R. The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. Am J Pathol 1975; 78: 71-100.
7. Pilcher BK, Dumin JA, Sudbeck BD, Krane SM, Welgus HG and Parks WC. The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix. J Cell Biol 1997; 137: 1445-1457.
8. Singer AJ and Clark RA. Cutaneous wound healing. N Engl J Med 1999; 341: 738-746.
9. Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 2003; 200: 500-503.
10. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003; 3: 23-35.
11. Mantovani A, Sozzani S, Locati M, Allavena P and Sica A. Macrophage polarization: tumorassociated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002; 23: 549-555.
12. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A and Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004; 25: 677-686.
13. Martinez FO, Helming L and Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 2009; 27: 451-483.
14. Stout RD, Jiang C, Matta B, Tietzel I, Watkins SK and Suttles J. Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J Immunol 2005; 175: 342-349.
15. Daley JM, Brancato SK, Thomay AA, Reichner JS and Albina JE. The phenotype of murine wound macrophages. J Leukoc Biol 2010; 87: 59-67.
16. Lucas T, Waisman A, Ranjan R, Roes J, Krieg T, Muller W, Roers A and Eming SA. Differential Roles of Macrophages in Diverse Phases of Skin Repair. J Immunol 2009.
17. Mosser DM and Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008; 8: 958-969.
18. Raes G, Noel W, Beschin A, Brys L, de Baetselier P and Hassanzadeh GH. FIZZ1 and Ym as tools to discriminate between differentially activated macrophages. Dev Immunol 2002; 9: 151-159.
19. Wynes MW and Riches DW. Induction of macrophage insulin-like growth factor-I expression by the Th2 cytokines IL-4 and IL-13. J Immunol 2003; 171: 3550-3559.
20. Torocsik D, Bardos H, Nagy L and Adany R. Identification of factor XIII-A as a marker of alternative macrophage activation. Cell Mol Life Sci 2005; 62: 2132-2139.
21. Martin P, D'Souza D, Martin J, Grose R, Cooper L, Maki R and McKercher SR. Wound healing in the PU.1 null mouse--tissue repair is not dependent on inflammatory cells. Curr Biol 2003; 13: 1122-1128.
22. Mirza R, DiPietro LA and Koh TJ. Selective and specific macrophage ablation is detrimental to wound healing in mice. Am J Pathol 2009; 175: 2454-2462.
23. Goren I, Allmann N, Yogev N, Schurmann C, Linke A, Holdener M, Waisman A, Pfeilschifter J and Frank S. A transgenic mouse model of inducible macrophage depletion: effects of diphtheria toxin-driven lysozyme M-specific cell lineage ablation on wound inflammatory, angiogenic, and contractive processes. Am J Pathol 2009; 175: 132-147.
24. Chen L, Tredget EE, Wu PY and Wu Y. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One 2008; 3: e1886.
25. Banno T, Gazel A and Blumenberg M. Effects of tumor necrosis factor-alpha (TNF alpha) in epidermal keratinocytes revealed using global transcriptional profiling. J Biol Chem 2004; 279: 32633-32642.
26. McKay IA and Leigh IM. Epidermal cytokines and their roles in cutaneous wound healing. Br J Dermatol 1991; 124: 513-518.
27. Hancock GE, Kaplan G and Cohn ZA. Keratinocyte growth regulation by the products of immune cells. J Exp Med 1988; 168: 1395-1402.
28. Rheinwald JG and Green H. Epidermal growth factor and the multiplication of cultured human epidermal keratinocytes. Nature 1977; 265: 421-424.
29. Li Y, Fan J, Chen M, Li W and Woodley DT. Transforming growth factor-alpha: a major human serum factor that promotes human keratinocyte migration. J Invest Dermatol 2006; 126: 2096-2105.
30. Schultz G, Rotatori DS and Clark W. EGF and TGF -alpha in wound healing and repair. J Cell Biochem 1991; 45: 346-352.
31. Marikovsky M, Vogt P, Eriksson E, Rubin JS, Taylor WG, Joachim S and Klagsbrun M. Wound fluid -derived heparin-binding EGF-like growth factor (HB-EGF) is synergistic with insulin-like growth factor-I for Balb/MK keratinocyte proliferation. J Invest Dermatol 1996; 106: 616-621.
32. Shirakata Y, Kimura R, Nanba D, Iwamoto R, Tokumaru S, Morimoto C, Yokota K, Nakamura M, Sayama K, Mekada E, Higashiyama S and Hashimoto K. Heparin-binding EGF-like growth factor accelerates keratinocyte migration and skin wound healing. J Cell Sci 2005; 118: 2363-2370.
33. Edwards JP, Zhang X and Mosser DM. The expression of heparin-binding epidermal growth factor-like growth factor by regulatory macrophages. J Immunol 2009; 182: 1929-1939.
34. Hallbeck AL, Walz TM and Wasteson A. Interleukin-6 enhances transforming growth factoralpha mRNA expression in macrophage-like human monocytoid (U-937-1) cells. Biosci Rep 2001; 21: 325-339.
35. Rappolee DA, Mark D, Banda MJ and Werb Z. Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping. Science 1988; 241: 708-712.
36. Grose R and Werner S. Wound-healing studies in transgenic and knockout mice. Mol Biotechnol 2004; 28: 147-166.
37. Massague J and Pandiella A. Membraneanchored growth factors. Annu Rev Biochem 1993; 62: 515-541.
38. Gallucci RM, Sloan DK, Heck JM, Murray AR and O'Dell SJ. Interleukin 6 indirectly induces keratinocyte migration. J Invest Dermatol 2004; 122: 764-772.
39. Chedid M, Rubin JS, Csaky KG and Aaronson SA. Regulation of keratinocyte growth factor gene expression by interleukin 1. J Biol Chem 1994; 269: 10753-10757.
40. Ashcroft GS, Yang X, Glick AB, Weinstein M, Letterio JL, Mizel DE, Anzano M, Greenwell-Wild T, Wahl SM, Deng C and Roberts AB. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol 1999; 1: 260-266.
41. Li AG, Wang D, Feng XH and Wang XJ. Latent TGFbeta1 overexpression in keratinocytes results in a severe psoriasis-like skin disorder. EMBO J 2004; 23: 1770-1781.
42. Sellheyer K, Bickenbach JR, Rothnagel JA, Bundman D, Longley MA, Krieg T, Roche NS, Roberts AB and Roop DR. Inhibition of skin development by overexpression of transforming growth factor beta 1 in the epidermis of transgenic mice. Proc Natl Acad Sci U S A 1993; 90: 5237-5241.
43. Werner S and Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003; 83: 835-870.
44. Werner S, Krieg T and Smola H. Keratinocytefibroblast interactions in wound healing. J Invest Dermatol 2007; 127: 998-1008.
45. Hubner G, Brauchle M, Smola H, Madlener M, Fassler R and Werner S. Differential regulation of pro-inflammatory cytokines during wound healing in normal and glucocorticoid-treated mice. Cytokine 1996; 8: 548-556.
46. Brauchle M, Angermeyer K, Hubner G and Werner S. Large induction of keratinocyte growth factor expression by serum growth factors and pro-inflammatory cytokines in cultured fibroblasts. Oncogene 1994; 9: 3199-3204.
47. Takehara K. Growth regulation of skin fibroblasts. J Dermatol Sci 2000; 24 Suppl 1: S70-77.
48. Beer HD, Florence C, Dammeier J, McGuire L, Werner S and Duan DR. Mouse fibroblast growth factor 10: cDNA cloning, protein characterization, and regulation of mRNA expression. Oncogene 1997; 15: 2211-2218.
49. Wang X, Waldeck H and Kao WJ. The effects of TGF-alpha, IL-1beta and PDGF on fibroblast adhesion to ECM-derived matrix and KGF gene expression. Biomaterials 31: 2542-2548.
50. Mori R, Shaw TJ and Martin P. Molecular mechanisms linking wound inflammation and fibrosis: knockdown of osteopontin leads to rapid repair and reduced scarring. J Exp Med 2008; 205: 43-51.
51. Stramer BM, Mori R and Martin P. The inflammation-fibrosis link? A Jekyll and Hyde role for blood cells during wound repair. J Invest Dermatol 2007; 127: 1009-1017.
52. Annes JP, Munger JS and Rifkin DB. Making sense of latent TGFbeta activation. J Cell Sci 2003; 116: 217-224.
53. Occleston NL, Fairlamb D, Hutchison J, O'Kane S and Ferguson MW. Avotermin for the improvement of scar appearance: a new pharmaceutical in a new therapeutic area. Expert Opin Investig Drugs 2009; 18: 1231-1239.
54. Postlethwaite AE, Keski-Oja J, Moses HL and Kang AH. Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta. J Exp Med 1987; 165: 251-256.
55. Border WA and Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994; 331: 1286-1292.
56. Grotendorst GR, Okochi H and Hayashi N. A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ 1996; 7: 469-480.
57. Igarashi A, Okochi H, Bradham DM and Grotendorst GR. Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell 1993; 4: 637-645.
58. Desmouliere A, Geinoz A, Gabbiani F and Gabbiani G. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 1993; 122: 103-111.
59. Direkze NC, Forbes SJ, Brittan M, Hunt T, Jeffery R, Preston SL, Poulsom R, Hodivala-Dilke K, Alison MR and Wright NA. Multiple organ engraftment by bone-marrow-derived myofibroblasts and fibroblasts in bone-marrow-transplanted mice. Stem Cells 2003; 21: 514-520.
60. Ishii G, Sangai T, Sugiyama K, Ito T, Hasebe T, Endoh Y, Magae J and Ochiai A. In vivo characterization of bone marrow-derived fibroblasts recruited into fibrotic lesions. Stem Cells 2005; 23: 699-706.
61. Herdrich BJ, Lind RC and Liechty KW. Multipotent adult progenitor cells: their role in wound healing and the treatment of dermal wounds. Cytotherapy 2008; 10: 543-550.
62. Brown LF, Yeo KT, Berse B, Yeo TK, Senger DR, Dvorak HF and van de Water L. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 1992; 176: 1375-1379.
63. Eming SA, Brachvogel B, Odorisio T and Koch M. Regulation of angiogenesis: wound healing as a model. Prog Histochem Cytochem 2007; 42: 115-170.
64. Li B, Sharpe EE, Maupin AB, Teleron AA, Pyle AL, Carmeliet P and Young PP. VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization. FASEB J 2006; 20: 1495-1497.
65. Dvorak HF, Brown LF, Detmar M and Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995; 146: 1029-1039.
66. Gerber HP, Dixit V and Ferrara N. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J Biol Chem 1998; 273: 13313-13316.
67. Odorisio T, Cianfarani F, Failla CM and Zambruno G. The placenta growth factor in skin angiogenesis. J Dermatol Sci 2006; 41: 11-19.
68. Frank S, Hubner G, Breier G, Longaker MT, Greenhalgh DG and Werner S. Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J Biol Chem 1995; 270: 12607-12613.
69. Babic AM, Chen CC and Lau LF. Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivo. Mol Cell Biol 1999; 19: 2958-2966.
70. Shimo T, Nakanishi T, Nishida T, Asano M, Kanyama M, Kuboki T, Tamatani T, Tezuka K, Takemura M, Matsumura T and Takigawa M. Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo. J Biochem 1999; 126: 137-145.
71. Nagy JA, Vasile E, Feng D, Sundberg C, Brown LF, Detmar MJ, Lawitts JA, Benjamin L, Tan X, Manseau EJ, Dvorak AM and Dvorak HF. Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J Exp Med 2002; 196: 1497-1506.
72. Maruyama K, Asai J, Ii M, Thorne T, Losordo DW and D'Amore PA. Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. Am J Pathol 2007; 170: 1178-1191.
73. Schledzewski K, Falkowski M, Moldenhauer G, Metharom P, Kzhyshkowska J, Ganss R, Demory A, Falkowska-Hansen B, Kurzen H, Ugurel S, Geginat G, Arnold B and Goerdt S. Lymphatic endothelium-specific hyaluronan receptor LYVE-1 is expressed by stabilin-1+, F4/80+, CD11b+ macrophages in malignant tumours and wound healing tissue in vivo and in bone marrow cultures in vitro: implications for the assessment of lymphangiogenesis. J Pathol 2006; 209: 67-77.
74. Ribatti D. The discovery of the placental growth factor and its role in angiogenesis: a historical review. Angiogenesis 2008; 11: 215-221.
75. Failla CM, Odorisio T, Cianfarani F, Schietroma C, Puddu P and Zambruno G. Placenta growth factor is induced in human keratinocytes during wound healing. J Invest Dermatol 2000; 115: 388-395.
76. Hattori K, Heissig B, Wu Y, Dias S, Tejada R, Ferris B, Hicklin DJ, Zhu Z, Bohlen P, Witte L, Hendrikx J, Hackett NR, Crystal RG, Moore MA, Werb Z, Lyden D and Rafii S. Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment. Nat Med 2002; 8: 841-849.
77. Adini A, Kornaga T, Firoozbakht F and Benjamin LE. Placental growth factor is a survival factor for tumor endothelial cells and macrophages. Cancer Res 2002; 62: 2749-2752.
78. Bottomley MJ, Webb NJ, Watson CJ, Holt L, Bukhari M, Denton J, Freemont AJ and Brenchley PE. Placenta growth factor (PlGF) induces vascular endothelial growth factor (VEGF) secretion from mononuclear cells and is co-expressed with VEGF in synovial fluid. Clin Exp Immunol 2000; 119: 182-188.
79. Carmeliet P, Moons L, Luttun A, Vincenti V, Compernolle V, De Mol M, Wu Y, Bono F, Devy L, Beck H, Scholz D, Acker T, DiPalma T, Dewerchin M, Noel A, Stalmans I, Barra A, Blacher S, Vandendriessche T, Ponten A, Eriksson U, Plate KH, Foidart JM, Schaper W, Charnock-Jones DS, Hicklin DJ, Herbert JM, Collen D and Persico MG. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 2001; 7: 575-583.
80. Autiero M, Waltenberger J, Communi D, Kranz A, Moons L, Lambrechts D, Kroll J, Plaisance S, De Mol M, Bono F, Kliche S, Fellbrich G, Ballmer-Hofer K, Maglione D, Mayr-Beyrle U, Dewerchin M, Dombrowski S, Stanimirovic D, Van Hummelen P, Dehio C, Hicklin DJ, Persico G, Herbert JM, Shibuya M, Collen D, Conway EM and Carmeliet P. Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med 2003; 9: 936-943.
81. Loots MA, Lamme EN, Zeegelaar J, Mekkes JR, Bos JD and Middelkoop E. Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. J Invest Dermatol 1998; 111: 850-857.
82. Wetzler C, Kampfer H, Stallmeyer B, Pfeilschifter J and Frank S. Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. J Invest Dermatol 2000; 115: 245-253.
83. Tchaikovski V, Olieslagers S, Bohmer FD and Waltenberger J. Diabetes mellitus activates signal transduction pathways resulting in vascular endothelial growth factor resistance of human monocytes. Circulation 2009; 120: 150-159.
84. Goren I, Muller E, Pfeilschifter J and Frank S. Severely impaired insulin signaling in chronic wounds of diabetic ob/ob mice: a potential role of tumor necrosis factor-alpha. Am J Pathol 2006; 168: 765-777.
85. Zykova SN, Jenssen TG, Berdal M, Olsen R, Myklebust R and Seljelid R. Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type II-like db/db mice. Diabetes 2000; 49: 1451-1458.
86. Fang Y, Shen J, Yao M, Beagley KW, Hambly BD and Bao S. Granulocyte-macrophage colonystimulating factor enhances wound healing in diabetes via upregulation of proinflammatory cytokines. Br J Dermatol 2009.
87. Ure I, Partsch B, Wolff K and Petzelbauer P. Granulocyte/macrophage colony-stimulating factor increases wound-fluid interleukin 8 in normal subjects but does not accelerate wound healing. Br J Dermatol 1998; 138: 277-282.
88. Cianfarani F, Tommasi R, Failla CM, Viviano MT, Annessi G, Papi M, Zambruno G and Odorisio T. Granulocyte/macrophage colony-stimulating factor treatment of human chronic ulcers promotes angiogenesis associated with de novo vascular endothelial growth factor transcription in the ulcer bed. Br J Dermatol 2006; 154: 34-41.
89. Deiters U, Barsig J, Tawil B and Muhlradt PF. The macrophage-activating lipopeptide-2 accelerates wound healing in diabetic mice. Exp Dermatol 2004; 13: 731-739.
90. Goren I, Muller E, Schiefelbein D, Christen U, Pfeilschifter J, Muhl H and Frank S. Systemic anti -TNFalpha treatment restores diabetes-impaired skin repair in ob/ob mice by inactivation of macrophages. J Invest Dermatol 2007; 127: 2259-2267.
91. Nahrendorf M, Swirski FK, Aikawa E, Stangenberg L, Wurdinger T, Figueiredo JL, Libby P, Weissleder R and Pittet MJ. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med 2007; 204: 3037-3047.
92. Cochain C, Rodero MP, Vilar J, Recalde A, Richart A, Loinard C, Zouggari Y, Guerin C, Duriez M, Combadiere B, Poupel L, Levy BI, Mallat Z, Combadiere C and Silvestre JS. Regulation of monocyte subsets systemic levels by distinct chemokine receptors controls postischemic neovascularization. Cardiovasc Res 2010;in press.